Prepare for scrutiny of birth control marketing after Dobbs

By Jennifer Romanski (August 1, 2022, 5:08 p.m. EDT) – Following the United States Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, many women are reassessing their approach to reproductive health care and taking steps to protect their access to necessary pharmaceuticals.

Suppliers of mail-order emergency contraception, also known as morning-after pills, have seen demand increase, forcing some to impose temporary limits on the number of pills per order.[1]

The pharmaceutical industry reacts to the end of Roe v. Wade by redirecting advertising budgets to emergency contraceptives, in some cases employing overtly political messages.

Implicitly evoking Judge Clarence Thomas’ agreement in Dobbs, Hey Favor Inc. —…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!